Want to see PMHS full AI Analyst Report?
PMHS Stock Chart & Stats
$0.08
-$0.02(-18.75%)
At close: 4:00 PM EDT
$0.08
-$0.02(-18.75%)
Day’s Range― - ―
52-Week Range$0.07 - $0.80
Previous CloseN/A
Volume100.00
Average Volume (3M)130.00
Market Cap
$8.51M
Enterprise Value$3.93
Total Cash (Recent Filing)$178.87K
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta-1.03
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding28,380,869
10 Day Avg. Volume0
30 Day Avg. Volume130
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-18.17
Price to Sales (P/S)34.26
P/FCF Ratio-56.08
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Strong Revenue Growth And Gross MarginRapid revenue expansion and a solid gross margin indicate meaningful product or service demand. If maintained, this provides a base for operating leverage, although the company must still reduce overhead substantially to convert growth into durable profitability.
No Reported DebtThe absence of reported debt limits near-term refinancing obligations and interest-related pressure. This gives the company more flexibility than a similarly loss-making, highly leveraged business, although negative equity and cash burn still constrain overall financial resilience.
Governance And Financial Leadership RefreshAdding an experienced CFO and refreshing board oversight could improve financial controls, reporting discipline, and strategic accountability. These changes are structurally relevant because stronger governance may support execution and stakeholder confidence as the company seeks funding.
Bears Say
Extreme Operating And Net LossesThe scale of operating and net losses shows that revenue growth is not yet translating into a viable earnings model. Unless expenses are reduced or revenue productivity improves materially, continued losses could consume capital and limit the company’s ability to scale sustainably.
Negative Stockholders’ EquityNegative equity indicates an impaired capitalization base and limited balance-sheet capacity to absorb further losses. It can also increase dependence on external capital, raising the longer-term risk of dilution or restructuring even though reported debt is currently zero.
Persistent Negative Cash FlowPersistent operating and free-cash-flow deficits mean the business is not funding operations internally. Even with improved cash burn versus 2025, ongoing outflows and large losses leave the company reliant on financing, creating durable funding and execution risk.
Polomar Health Services News
PMHS FAQ
What was Polomar Health Services’s price range in the past 12 months?
Polomar Health Services lowest stock price was $0.07 and its highest was $0.80 in the past 12 months.
What is Polomar Health Services’s market cap?
Polomar Health Services’s market cap is $8.51M.
When is Polomar Health Services’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Polomar Health Services’s earnings last quarter?
Currently, no data Available
Is Polomar Health Services overvalued?
According to Wall Street analysts Polomar Health Services’s price is currently Overvalued.
Does Polomar Health Services pay dividends?
Polomar Health Services does not currently pay dividends.
What is Polomar Health Services’s EPS estimate?
Polomar Health Services’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Polomar Health Services have?
Polomar Health Services has 28,380,869 shares outstanding.
What happened to Polomar Health Services’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Polomar Health Services?
Currently, no hedge funds are holding shares in PMHS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Polomar Health Services
Polomar Health Services, Inc. operates as a retail compounding pharmacy. The company owns SlimRx, a weight loss focused online platform connects patients with licensed physicians to prescribe weight loss medications, such as semaglutide compounded with vitamin B-12 and/or metformin; and intends to launch PoloMeds for diabetes medications, including metformin compounds, sulfonylureas, and insulin, as well as compounded erectile dysfunction medications inhalable sildenafil. It also includes dermatological formulations for the treatment of acne, alopecia areata, basal cell carcinoma, Becker’s nevus, vitiligo, and other common skin conditions. In addition, it provides prescription fulfillment services for third party web based tele-health platforms. The company is based in Los Angeles, California.
Technical Analysis
PainReform
―
Universe Pharmaceuticals
―
Bluejay Diagnostics
―
NewGenIvf Group
―
Mobile-health Network Solutions Class A
―